Retinol-binding protein-4 in experimental and clinical metabolic disease.
about
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasisTranscriptional targets in adipocyte biologyVitamin A metabolism: an update.Circulating retinol binding protein 4 in critically ill patients before specific treatment: prognostic impact and correlation with organ function, metabolism and inflammation.Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitusAdipokines and insulin resistanceAdipocytokines and the metabolic complications of obesity.RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans.Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects.Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children.Association of RBP4 genetic variants with childhood obesity and cardiovascular risk factors.Targeted Vezf1-null mutation impairs vascular structure formation during embryonic stem cell differentiation.Free fatty acid binding protein-4 and retinol binding protein-4 in polycystic ovary syndrome: response to simvastatin and metformin therapies.Male mice are susceptible to high fat diet-induced hyperglycaemia and display increased circulatory retinol binding protein 4 (RBP4) levels and its expression in visceral adipose depots.Circulating retinol-binding protein 4 concentrations in patients with coronary artery disease and patients with type 2 diabetes mellitus
P2860
Q33449878-DED89881-B57F-4363-9251-FEB9E9E12BBEQ34192987-763FF642-D8A1-48C9-BFD2-FBA0CBC26EBAQ34591540-9E3AD460-149A-4472-BB20-F92189215635Q35559233-939253BE-577A-4823-8885-4453EB82F5E4Q36185223-80FD2538-D710-4B05-80C4-888A4BABADBFQ36972589-FD3A30A3-32B5-4182-945F-21CD3673E477Q36979754-D8CAE672-080E-40E6-AA94-E5405980C16EQ37222431-1D055717-476E-475F-8299-AF402449B21FQ37400624-71B3E81B-D849-404F-90FF-7F39E0BF14D4Q39812280-9219A278-2617-4E49-96D8-1DADDED1C932Q40269808-223429EB-C642-40F5-8129-EB490C08FDF8Q42733613-DC18508A-43F3-4A7A-9BA7-23F38A96FA0AQ43739691-5D44EBE2-0615-4CF6-A9EF-F005AEE60531Q50955706-ECFF022A-CE4F-4A20-8E12-485660CBD74EQ58196746-7AAED8DE-7A47-4BC6-B738-E72D3B28E4EF
P2860
Retinol-binding protein-4 in experimental and clinical metabolic disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Retinol-binding protein-4 in experimental and clinical metabolic disease.
@en
Retinol-binding protein-4 in experimental and clinical metabolic disease.
@nl
type
label
Retinol-binding protein-4 in experimental and clinical metabolic disease.
@en
Retinol-binding protein-4 in experimental and clinical metabolic disease.
@nl
prefLabel
Retinol-binding protein-4 in experimental and clinical metabolic disease.
@en
Retinol-binding protein-4 in experimental and clinical metabolic disease.
@nl
P2860
P356
P1476
Retinol-binding protein-4 in experimental and clinical metabolic disease.
@en
P2093
Maximilian von Eynatten
Per M Humpert
P2860
P304
P356
10.1586/14737159.8.3.289
P577
2008-05-01T00:00:00Z